The objectives of hemodialysis have moved from the diffusive clearance of small molecular weight uremic toxins and achieving dialyzer urea adequacy targets to emphasis on improving clinical outcomes in end stage renal failure patients by increasing larger sized uremic toxin clearance. Clinical emphasis in the last few decades has focused on increasing middle molecule weight toxin clearance by hemodiafiltration. Although long-term data is still lacking, short-term outcomes appear promising. Advancements in nanotechnology have now introduction a new generation of medium cut-off membrane dialyzers which allow diffusive clearance of similar middle molecular weight uremia toxin clearance as hemodiafiltration, without increased albumin losses. As these dialyzers have only recently been introduced into clinical practice, no long-term outcomes are available to determine the relative benefits or advantages of this approach. As dialyzers are now designed to maximize diffusive or convective clearance, or provide a combination, then clinicians can now choose dialyzers tailored to the individual patient needs depending on clinical circumstances. We review the key important features in choosing a dialyzer for patients with end stage renal failure and acute kidney injury.
INTRODUCTION
The constant search to improve outcomes for patients with end stage renal failure and advancements in nanotechnology manufacturing processes have led the development of dialyzers with increased uremic toxin clearance. The previous focus on small water-soluble solutes commonly used as a surrogate marker for dialysis adequacy has now shifted to middle-molecule and protein-bound uremic toxin clearance. Overcoming the challenge of what has been termed "difficult to remove uraemic toxins," is contingent on developing a dialyzer that is both highly permeable but yet selective in clearance of these toxins while preventing the loss of important molecules including vitamins, albumin, and immunoglobulins. 1, 2 Although removal of middlemolecule and protein-bound uremic toxin toxins has been beneficial in short-term studies, longer term data to support this hypothesis is awaited. 3, 4 The choice of dialyzer in clinical practice is a balance between dialyzer performance and cost. One size does not fit all and the choice will depend upon dialysis facility and patient population.
Dialyzer flux
Originally the term dialyzer "flux" was defined by the ultrafiltration coefficient (Kuf ), with high flux dialyzer Kuf >15 mL/h/mmHg. However, dialyzer flux was subsequently redefined according to β2 microglobulin clearance rather than hydraulic permeability following reports of improved outcomes from middle molecular weight uremic toxin removal. 5 Low flux, mid flux, and high flux are currently defined as β2 microglobulin clearance of <10, 10-20, and >20 mL/min respectively. 6 High-flux dialyzers, also sometimes defined a β2 microglobulin sieving coefficient >0.6, can potentially remove solutes between 10 and 50 kDa, depending upon the dialyzer. Outcome data reporting benefit compared to low flux dialyzers are predominantly from observational reports and post hoc analysis. [7] [8] [9] Over time, cost differentials have narrowed and high-flux dialyzers have now become the standard of care in most developed countries.
A new generation of high flux dialyzers have been recently introduced, and these are described by molecular weight cut-off [MWCO] and molecular weight retention onset [MWRO] . MWRO and MWCO refer to the molecular weight/radius at which the sieving coefficient value is 0.9 and 0.1, respectively. These highly permeable high cut-off or super-flux dialyzers have a MWCO ≤65 kDa, and increase the clearance of cytokines, free light chains, and myoglobin. [10] [11] [12] [13] [14] Unfortunately, the nonuniformity of the pore sizes led to a significant gap between the MWRO and MWCO values, resulting in loss of important molecules such as albumin, although no adverse outcomes were reported in short-term studies. 15 The nonspecific and nonselective characteristics of these highly permeable membranes theoretically can remove significant vitamins, trace elements, neuro-transmitters, small peptides, and hormones that may have an impact in the longer term. Therefore, the clinical use for these superflux dialyzers may be limited to acute short-term use for the removal of larger solutes, such as light chains or myoglobin in treating acute kidney injury (AKI).
Bio-incompatibility
Bio-incompatibility of dialyzer membranes can be defined as the sum of the specific interactions between blood and the dialyzer membranes or absence of any perturbations in the blood elements. 6, 16 Contact of blood with the dialyzer membrane can trigger an inflammatory process. Studies have suggested greater erythropoietin responsiveness and longer life expectancy for patients dialyzing with less bio-incompatible membranes.
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Bio-incompatibility also includes the effects of sterilants, potting compound, and chemicals leached from the extracorporeal circuit. Apart from unmodified cuprophan membranes being inferior, there does not appear to any clinically significant differences in terms of bio-incompatibility with the current generation of dialyzers, 18 and as such bioincompatibility is no longer a contentious issue. [19] [20] [21] Vitamin E coated dialyzers potentially may have an antioxidative effect, and small studies have suggested greater response to erythropoietins. 22, 23 However, these preliminary reports have not been substantiated to show more robust and sustained benefits.
Mass transfer-area coefficient
Mass transfer-area coefficient (KoA) refers to permeability of the mass transfer barrier between blood and dialysate pathways by diffusion. 24 Ko is the mass transfer coefficient and A is surface area of the dialyzer membrane. KoA of a dialysis membrane depends on the pore density, pore size distribution, and resistance to solute passage. Higher values indicate more efficient dialyzers. in vitro measured Kt/v during dialysis is often much lower than that achieved in clinical practice. 25, 26 Dialyzer manufacturers KoA values for urea, should be reduced by around 20% to reflect clinical practice. 27 Although theoretically KoA is constant for a given dialyzer, increasing nominal dialysate flow (Qd) from 500 to 800 mL/min alters the mass transfer characteristics of hollow fiber hemodialyzers with a larger increase in clearance than that predicted by assuming a constant KoA. 
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Hydraulic permeability
Hydraulic permeability of a dialyzer or its ultrafiltration coefficient (Kuf ) is a measure of the rate and amount of water flow across the dialyzer membrane. Kuf is the limiting factor for ultrafiltration flow and volume, hence it is a very important when choosing a dialyzer for convective therapies. Ultrafiltration flow (Quf ) is not linearly related to Kuf but follows a parabolic function. 28 As such there is a vertex point which defines the optimal Quf of a dialyzer, as opposed to the maximum Quf, which is frequently associated with hemoconcentration, increased clotting, and loss of effective dialyzer surface area. 28 
DIALYZER DESIGN AND CLEARANCE
The dialyzer can be divided to the header, body and inlet, outlet for both blood, and dialysate. The other clinically important components with the dialyzer are the fiber capillaries and baffle which determine the blood and dialysate flow pathways ( Figure 1 ). Blood enters and leaves the dialyzer through the dialyzer header and is rapidly dissipated into a series of narrow-diameter parallel capillary fibers. In contrast, dialysate enters and leaves via ports in the main body of the dialyzer. Dialyzer designs can have an impact on clearance, in addition to countercurrent blood flow, increase relative flow, concentration gradient resistance to solute passage, hydrophobicity, and electrical charges. 26, 29, 30 Diffusive clearance For diffusive clearance, increasing both blood and dialysate flow optimizes the concentration gradient clearance while ensuring maximum contact surface area between blood and dialyzer surface. Blood flow tends to be greater in the center 
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core fibers with slower blood flow through the outer fibers. As a result, there is reduced diffusional clearances and increased risk of clotting in these outer fibers. Small solute clearances increase with increasing blood flow up to a certain level and then plateau. To improve the flow velocity in both the outer capillary fibers and also distribution throughout the capillary fibers, design measures includes introducing an "O" ring around the midpoint of the fibers or shaping the outer dialyzer casing to have a narrower middle segment thus producing a vortex-like effect and introducing a helical or spiral flow pattern as blood enters the dialyzer header, respectively. 30, 31 As for dialysate flow, it has to be directed to the end of the dialyzer, reducing dead space area and channeling, to optimize clearance. The baffle is placed at both the dialysate inlet and outlet to direct the incoming and outflowing dialysate. Baffles that had a 360 angle, a 25-mm taper length and a small angle of around 4.2 , have been reported to maximally improve solute clearances by better channeling the dialysate between the capillary fibers.
32 Dialyzer designs to reduce channeling emphasize on creating spaces between the hollow fibers and baffle. Although introducing mechanical spaces using spacer yarn, spaces filaments or wavy fibers (Moire effect) will reduce the effective surface area within the dialyzer casing, these spaces will facilitate dialysate flow and provide greater effective surface area for diffusion, so enhancing clearance. This is why small solute clearances can vary with higher dialysate flow rates depending on dialyzer design configuration.
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Convective clearance
Larger sized uremic solutes are better removed by convective clearance compared to diffusion using the same dialyzer. To improve convective clearance, a balance has to be achieved between a larger internal diameter to allow for greater convective movement yet maintaining a lower filtration fraction and a smaller diameter to generate a higher hydrostatic pressure needed to drive convection. 30, 32, 38 Membrane polymer materials have an effect on convective clearance with polyamide having greater natural hydraulic permeability than polysulfone. The addition of increasing amounts of polyvinylpyrolidone (PVP) increases both pore size and hydraulic permeability of polysulfone membranes. 39 
Absorption
There is some solute clearance by membrane adsorption during dialysis. This is dependent on membrane hydrophilicity, surface area, roughness, charge, and chemical composition. 6, 30 Toray Industries (Tokyo, Japan) developed a Polymethylmethacylate (PMMA) membrane with a homogeneous rather than asymmetric pore structure designed to increase middle molecule adsorption. 40, 41 Reports using this dialyzer have suggested better humoral immunity, greater clearance of free light chains, and response to erythropoietins, reduced pruritis, adsorption of intact parathyroid hormone, and preservation of muscle mass. [42] [43] [44] [45] However, it is important to note that although adsorption may improve middle molecular weight clearance, there will be a reduction in diffusional and convective clearance due to increased membrane protein deposition.
DIALYZER DESIGN AND CLOTTING
While adequate anticoagulation is the key to maintaining circuit patency, dialyzer designs can have an impact on clotting and thus clearance. Designs to reduce clotting are centered on reducing protein deposition on the surface of the dialyzer capillary fiber. Some of these includes a wavy undulation configuration of capillary fiber and generating flows within dialyzer that prevent protein deposition. 36, 46, 47 Although heparin bonding to the dialyzer surface has not been successful in allowing anticoagulant free dialysis, other surface treatings are being developed, such as the Hydrolink™ NV hydrophilic polymer designed to increase adsorbed water at the blood membrane interface, aimed at anti-thrombogenic and antifouling effects. 48 
MEMBRANE MANUFACTURING AND PROCESSING
Membrane materials commonly used for dialyzers included natural substituted cellulose (cellulose acetate, diacetate, triacetate as by adding these side groups reduces bio-incompatibility), and synthetic membranes including polysulfone, polyacrylonitrile, polycarbonate, polyamide, and polymethylmethacrylate. Negatively charged AN69 (Hospal, Lyon, France) dialyzers increased bradykinin generation, which could be exacerbated by prescription of angiotensin converting enzyme inhibitors.
Most dialyzer membranes have electrical charges, termed Z potential. This results from the process of polymerization and the chemical composition together with polymer blending. 49 This electrical potential occurs due to the presence of electronegative charges located in the skin layer of the membrane. 49 Membrane fouling may occur as a result of this electrical gradient and thus reduce dialyzer performance. 50 Dialyzers are checked to ensure that the capillary fibers are intact and will not leak blood. If a leak is found, manufacturers may either discard the dialyzer or attempt a by sealing the damaged fibers with potting material. 51 Sealing will reduce the actual effective surface area of the capillary fibers, but of greater concern is that the fluid used to test fiber integrity, perfluorohydrocarbons (PF5070), 52 may be retained within the repaired dialyzer, and then become a gas when warmed to body temperature, resulting in a gas embolism. More than 50 cases of gas emboli were reported between 2001 and 2002 across continents due to the use of PF5070 in repaired Althane dialyzers. [52] [53] [54] Following this incident, the majority of manufacturers no longer repair dialyzers.
Dialyzer sterilization can be achieved via steam, ethylene oxide (ETO), electron beam, or gamma irradiation. The preferred method of sterilization is steam serialization. Steam-sterilized membranes have been found to improve endothelial cell viability when compared to ETO or gamma rays-sterilized ones. 55 Most manufacturers have now opted to stop using ETO following various reported IgE-mediated reactions despite studies suggesting that ETO reactions are preventable by adequate degassing of the dialyzer by the manufacturer and by adequate rinsing of the dialyzer just prior to use. 52 Electron beam sterilization on the other hand has been reported to cause significant thrombocytopenia following dialysis. 56 Although most dialyzers are now sterilized by steam method, most bloodlines are still sterilized with ETO, and so allergic reactions can still occur.
DIALYZER REUSE
Dialyzer reuse has the potential advantage of cost efficiency, improving bio-incompatibility, and reducing the risk of first use syndrome associated with ETO sterilization. 57, 58 However, the majority of dialyzers are no longer sterilized with ETO. The choice of reusing dialyzers vs. single use needs to be balanced against manpower cost and the need to establish and maintain processing standards and testing for dialyzer reuse. This requires maintaining equipment records, ensuring adequate dialyzer performance, adequate sterilization, testing for germicide removal before use, quality assurance of reprocessed dialyzers, and quality control records. There have been reports of adverse patient outcomes arising from errors or lapses, hazard to health care professionals and risk of infection (both bacteremia and blood borne viruses) associated with dialyzer reuse. [59] [60] [61] [62] The outcomes of dialyzer reuse in terms of hospitalization risk and mortality is inconclusive. [63] [64] [65] Given the lower costs of dialyzers, single use dialyzers have now become the standard of care in developed countries. If dialyzer reuse is practiced, then dialyzers should be reprocessed following the Association for the Advancement of Medical Instrumentation Standards and Recommended Practices. 66, 67 The processes involves rinsing, cleaning, performance testing, and finally testing for absence of cleaning agents and germicides. Cleansing agents used include hydrogen peroxide, sodium hypochlorite (bleach), and pressurized water, and germicides include formaldehyde, glutaraldehyde and peracetic acid, heated citric acid, or in combination. 63, 64, [68] [69] [70] After sterilization, dialyzers need to be tested for residual germicides before use, as inadequate removal will expose patients to germicides leading to chemical and allergic reactions.
The different germicides, cleaning agents, and processing methods have varying effects on protein deposition and membrane porosity. Interestingly, clearance of uremic toxins after reuse also differs according to molecular weight. Studies 71, 72 demonstrated that maintenance of small solute clearance during reuse of high-flux dialyzers does not ensure the maintenance of larger solute clearance. However, the addition of bleach as a cleaning agent or processing with heat and citric acid improves β2 microglobulin clearance. 73, 74 Dialyzer performance decreases with reuse due to the occlusion of fibers, protein adsorption, and secondary membrane formation. All reused dialyzers need to be tested for leaks and fiber-bundle volume (FBV) to ensure safety and satisfactory performance. The National Kidney Foundation recommends that dialyzers for reuse should have a blood compartment volume ≥80% of the original measured volume or a urea (or ionic) clearance ≥90% of the original clearance. 67 If FBV is measured, then Kt/Vurea or urea reduction ratio (URR) will still need to be measured to estimate dialyzer performance as FBV does not ensure acceptable urea clearances. 67 Most centers limit the maximum number of reuses to 15, as thereafter there is a usually a significant decline in dialyzer performance as well the cost of reprocessing will exceed that of a new dialyzer beyond a certain number of reuses.
DIALYZER CHOICE IN AKI AND IN CRITICAL CARE
Factors to consider in choosing a dialyzer for a patient with AKI patient include membrane composition, dialyzer surface area, and membrane flux. Unmodified cellulosic membranes were associated with greater activation of complement and inflammatory cells compared to synthetic membranes and were reported to delay renal recovery. 75, 76 Dialyzer and clearance Hemodialysis International 2018; 22:S65-S74
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Meta-analyses showed that both patient survival and renal recovery were reduced with unmodified cellulosic dialyzers, but there were no such effects with either modified cellulosic or synthetic membrane dialyzers. 19, 77, 78 Smaller surface area dialyzers are to be preferred to prevent dialysis equilibrium syndrome, whereas when treating poisoning or drug toxicity, then a larger sized dialyzer is preferred to increase clearance. [79] [80] [81] Dialyzer flux is also an important determinant of clearance, in particular middle-sized molecules. High-cut-off membranes and the new generation medium cut-off membranes may potentially have a role in the management of light nephropathy along with appropriate chemotherapy. However, the actual reported clinical outcomes using these high cut-off membranes remain inconclusive. 3, [82] [83] [84] 
INCREASING MIDDLE MOLECULAR WEIGHT SOLUTE CLEARANCE
To improve patient outcomes, there has been much focus placed on middle molecular weight solute clearance (≥500 Da and < 60 kDa ). Once residual renal function is lost, middle sized solutes are retained, and both prolonged dialysis session time and hemodiafiltration improve clearance compared to standard high-flux dialysis. Extended dialysis time in nocturnal or home dialysis programs may not be necessarily acceptable to all patients and this option needs to be weighed against the impact on quality of life. The effect of high volume hemodiafiltration on survival is still not conclusive to date, although various post hoc reports have demonstrated a clinical benefit with increased convective volume while still cost effective. [85] [86] [87] Centers, particularly in Europe, have converted to convective-based therapy given the possibility of superior outcomes. 88 However, to achieve the higher convective volumes suggested by recent clinical trials, patients require reliable blood access to provide higher blood flow rates, and this that may not be possible for all patients. 89 The emphasis on middle molecule clearance has led to the development of high retention onset membranes (HRO), also called medium cut-off membranes. These membranes can remove larger middle molecules up to 45 kDA by diffusion. 3 The concept of HRO is based on the steep curve between MWRO and MWCO, which is achieved by a narrowed distribution of pore sizes. 90 This ability to produce a steep sieving coefficient curve shifts the entire curve to the right, enabling the removal of larger molecules protein but reducing albumin (66 kDa) losses compared to the earlier high-cut-off dialyzer membranes. 90 Larger middle-sized solute clearances can therefore be achieved by the relatively large sieving coefficients, in addition to the usual internal filtration and back-filtration with high flux dialyzers. 91 Hemodialysis treatment with this membrane is termed expanded hemodialysis (HDx), and only requires a standard hemodialysis machine.
So far, only limited data is available with HDx confirming efficient removal of larger middle-sized solutes, including λ free light chains, reduced transcription of proinflammatory cytokines in peripheral leukocytes, removal of soluble mediators, and significantly improved endothelial function when compared with the existing extracorporeal therapies. 3, 85 There have proposals as to which patients would potentially benefit using this dialyzer. 90, 91 However, there is still much to be resolved with this new generation of dialyzers. It is not completely certain that there will be no adverse longer term consequences of the higher asymptomatic loss of albumin and other smaller molecular weight proteins compared to high flux hemodialysis and hemodialfiltration. 3 Studies reporting patient's and caregiver reported outcomes, and any actual benefit to patient comorbidity and survival are awaited.
CONCLUSION
Advances in nanotechnology have allowed technological developments in dialyzer design and manufacturing, to allow both more effective small solute clearances, and also a greater range of solute clearance. This has led to new designs which improve the blood and dialysate pathway flows within the dialyzer to maximize the concentration gradient and improve diffusive clearances. In addition with increasing interest in hemodiafiltration, dialyzers specifically designed for convective clearance are now available, combining high hydraulic permeability with dialyzer fiber dimensions to balance fiber diameter, length, and hydraulic pressure to allow high volume hemodiafiltration while preventing an increased filtration fraction. Manufacturing processes have now allowed the production of higher cut-off dialyzer membranes, allowing similar diffusional clearances of middle-sized uremic toxins compared to hemodiafiltration, without excessive albumin losses. Although there is no ideal dialyzer which can effectively clear all types of uremic toxins and at the same time retain vitamins and other essential factors, improving the range of uremic toxin clearance is most likely to result in patient benefits (Table 2) . However, definitive studies are required to demonstrate additional benefits of these new generation of dialyzers over standard high-flux membranes.
